LD-2 disclosure · 3rd Quarter - Report
LUMARA HEALTH
Client
- Name
- LUMARA HEALTH
- Description
- specialty pharmaceutical company
- Location
- Missouri · United States of America
Registrant
- Description
- lobbying firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
Issues related to FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, H.R.4800/S.2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 and H.J.Res.124, Continuing Appropriations Resolution, 2015.
LobbyistsJOHN GREEN · STEWART HALL · HUNTER MOORHEAD · MATT WISE · STEVE TILTON · MATHEW LAPINSKI · mr TODD MATTHEW WEISS · ms ANNE BRADY · JAKE PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.
LobbyistsJOHN GREEN · STEWART HALL · HUNTER MOORHEAD · MATT WISE · STEVE TILTON · MATHEW LAPINSKI · mr TODD MATTHEW WEISS · ms ANNE BRADY · JAKE PERRY
TargetedSENATE · HOUSE OF REPRESENTATIVES